Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Concurrent Session 4: Targeting the Innate Immune System

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Integrating anti-GD2 therapies and fusokines with NK cells for pediatric solid tumors
Christian M Capitini
University of Wisconsin, Madison, WI, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
Genetically Engineered Natural Killer Cell Lines For Treatment of Cancer
Hans Klingemann
NantKwest, Inc., Woburn, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
Exploring Approaches to Optimize NK Cell-Based Immunotherapy for Cancer
Richard W Childs
National Heart, Lung, and Blood Institute, Bethesda, MD, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 28, 2019 4:15 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3